Financial News Feed

Today ZEAL ranks # as BUY CANDIDATE.
Today ZEAL ranks # as BUY CANDIDATE.

ZEAL stock Zealand Pharma

ZEAL stock
Zealand Pharma

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we’ll take a look at the Price to Cash Flow ratio of Zealand Pharma A/S (CPSE:...

Read more

Here will take a quick scan of Earnings Yield information on shares of Zealand Pharma A/S (CPSE:ZEAL). Currently, the Earnings to Price (Yield) is 0.202196, Earnings Yield is 0.338097, and Earnings Yi...

Read more

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the ...

Read more

Placing Zealand Pharma A/S (CPSE:ZEAL) shares under the microscope we note that the firm has a current Return on Equity of 0.480131. Simply put, this ratio determines how well the firm uses investment...

Read more

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction. The Shareholder...

Read more

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Zealand Ph...

Read more

Falck Renewables S.p.A. (BIT:FKR) has a Q.i. Value of 25.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The pu...

Read more

The Piotroski F-Score of Zealand Pharma A/S (CPSE:ZEAL) is 3. The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a compan...

Read more

Investors are constantly examining different company financial indicators to assess trading opportunities. Zealand Pharma A/S (CPSE:ZEAL) presently has an EV or Enterprise Value of 1877401. The EV is ...

Read more

Zealand Pharma A/S (CPSE:ZEAL) currently has a current ratio of 5.30. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current ...

Read more

Zealand Pharma A/S (CPSE:ZEAL) boasts a Price to Book ratio of 2.159158. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book to di...

Read more

Zacks Investment Research upgraded shares of ZEALAND PHARMA/S (NASDAQ:ZEAL) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. Zacks Investment Research curr...

Read more

The stock of Zealand Pharma A/S – American Depositary Shares (NASDAQ:ZEAL) registered an increase of 0.28% in short interest. ZEAL’s total short interest was 144,000 shares in January as published...

Read more

The EBITDA Yield for Endeavour Mining Corporation (TSX:EDV) is 0.143011. The EBITDA Yield is a great way to determine a company’s profitability. This number is calculated by dividing a company’s e...

Read more

Zealand Pharma A/S (CPSE:ZEAL) has seen cash flow growth over the past year of 5.50347. Cash flow and cash flow growth can reveal to an investor how quickly the firm is generating inflows of cash from...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank